Pressure BioSciences Raises $500K | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences has raised $500,000 in the second tranche of its $2.5 million Series B private placement.

The South Easton, Mass.-based firm sold units at $18.80 each. The units consisted of one share of non-voting Series B Convertible Preferred Stock, and one warrant to purchase a share of Series B Convertible Preferred Stock at an exercise price of $28.80 per share, expiring on Aug. 11, 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.